First News ServiceAt a CAGR Of 19.9% Synthetic Biology Market $8.84 Billion By 2022 – Market By Tool, Technology, Application, IndustryMedgadget (blog)Based on technology, the synthetic biology market is segmented into gene synthesis, genome engineerin… Continue reading
Immuno-Oncology NewsMore Mutations in Melanoma Cells Predict Better Responses to ImmunotherapyImmuno-Oncology NewsAlthough the treatment outcomes are promising, only a limited number of melanoma patients (fewer than 50 percent) respond to this type of … Continue reading
ERC grant: €2 million for synthetic biology at TU DarmstadtEurekAlert (press release)This will further strengthen the activities of TU Darmstadt in the domain of synthetic biology. The prestigious ERC Consolidator Grant for Heinz Koeppl is linked to th… Continue reading
Los Angeles Times |
CRISPR: The Latest Edition
Science Magazine (blog) There’s a rather large breakthrough in CRISPR gene editing – yeah, another one – that has downstream implications for drug discovery. A group at the Salk Institute reports in Cell that they’ve found a way to do both loss- and gain-of-function without … Scientists use CRISPR to turn genes on without editing their DNALos Angeles Times CRISPR/Cas9 Edits Epigenome with Therapeutic EfficiencyGenetic Engineering & Biotechnology News Diabetes and muscular dystrophy could be treated effectively with modified Crispr genetic engineering techniqueThe Independent Futurism –New Atlas –The Guardian all 42 news articles » |
|
United States: US FDA Advisory Committee Backs Gene Therapy For Rare Form Of Blindness
Mondaq News Alerts On October 12, 2017, the U.S. Food and Drug Administration’s (FDA) Cellular, Tissue and Gene Therapies Advisory Committee has paved the way for the agency’s first approval of a gene therapy to treat a disease caused by a genetic mutation. A panel of … |